Linical Named CRO Company of the Year 2025, at Global Health & Pharma Magazine’s Global Excellence Awards

Linical provides clients with a gateway to global clinical development. With a presence across The Americas,
Europe, and Asia-Pacific, Linical helps pharmaceutical and biotechnology companies streamline regulatory
approvals, enroll the right patients, and capture high-quality data

with speed and precision.

Linical is proud to have recently been named as CRO Company of the Year in the 2025 Global Excellence Awards presented by Global Health & Pharma Magazine. The Global Excellence Awards highlight companies around the world who are delivering exceptional performance and impactful services in the health, pharmaceutical, and life sciences sectors.

Following on from our award, Linical has recently been featured in an article for Global Health & Pharma Magazine (Q4 2025) analyzing how we provide clients with a 'gateway to success' in global clinical development. The article looks at Linical's key differentiators and deep therapeutic expertise needed to deliver successful results.

This article is taken from Global Health & Pharma Magazine Q4 2025, page 14 . © AI Global Media Ltd